| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1008586337 |
| P356 | DOI | 10.1186/BCR2577 |
| P932 | PMC publication ID | 2917018 |
| P698 | PubMed publication ID | 20550729 |
| P5875 | ResearchGate publication ID | 44675751 |
| P2093 | author name string | Philippe Delannoy | |
| Sylvain Julien | |||
| Joy Burchell | |||
| Aurélie Cazet | |||
| Marie Bobowski | |||
| P2860 | cites work | Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer | Q77343384 |
| Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients | Q79811205 | ||
| A polyvalent vaccine for high-risk prostate patients: "are more antigens better?" | Q80588075 | ||
| Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc | Q81563612 | ||
| Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA? | Q83921259 | ||
| High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas | Q21195240 | ||
| Alpha1,3-fucosyltransferase IX (Fuc-TIX) is very highly conserved between human and mouse; molecular cloning, characterization and tissue distribution of human Fuc-TIX | Q22010185 | ||
| Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase | Q24310094 | ||
| Expression cloning of a GM3-specific alpha-2,8-sialyltransferase (GD3 synthase) | Q24315780 | ||
| Molecular cloning of a cDNA encoding a novel human leukocyte alpha-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant | Q24316888 | ||
| A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha(1,3/1,4)fucosyltransferase | Q24318318 | ||
| Genes that mediate breast cancer metastasis to the brain | Q24644008 | ||
| Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. | Q30873025 | ||
| Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation | Q31051680 | ||
| Tn-syndrome | Q33330685 | ||
| Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry | Q33334654 | ||
| Molecular plasticity of E-cadherin and sialyl lewis x expression, in two comparative models of mammary tumorigenesis. | Q33493076 | ||
| The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression | Q33833952 | ||
| Tissue distribution of histo-blood group antigens | Q33852459 | ||
| Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA. | Q34207920 | ||
| Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer | Q34428742 | ||
| Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene | Q34433644 | ||
| The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer. | Q34471553 | ||
| Rationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancer | Q35079193 | ||
| Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11 | Q35249810 | ||
| Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer. | Q35623390 | ||
| Selectin ligands | Q35634175 | ||
| Ganglioside/glycosphingolipid turnover: new concepts | Q35824021 | ||
| Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells | Q36643004 | ||
| Lewis x is highly expressed in normal tissues: a comparative immunohistochemical study and literature revision | Q36868517 | ||
| Sweet preferences of MGL: carbohydrate specificity and function | Q37076732 | ||
| Promoter structure and transcriptional regulation of human beta-galactoside alpha2, 3-sialyltransferase genes | Q37130700 | ||
| Nanotechnology for breast cancer therapy | Q37229262 | ||
| A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction | Q37328722 | ||
| Human carcinoma-associated precursor antigens of the NM blood group system | Q37951984 | ||
| Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. | Q38307814 | ||
| Comparison of the carbohydrate-binding specificities of seven N-acetyl-D-galactosamine-recognizing lectins | Q38339969 | ||
| Predictive value of lectin binding on breast-cancer recurrence and survival | Q38349289 | ||
| Immunochemical studies on the specificity of the peanut (Arachis hypogaea) agglutinin | Q38359318 | ||
| Differential contributions of recognition factors of two plant lectins -Amaranthus caudatus lectin and Arachis hypogea agglutinin, reacting with Thomsen-Friedenreich disaccharide (Galbeta1-3GalNAcalpha1-Ser/Thr). | Q38360639 | ||
| Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. | Q39724089 | ||
| Quantitative computerized image analysis of Tn and T (Thomsen-Friedenreich) epitopes in prognostication of human breast carcinoma | Q73740079 | ||
| Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides | Q73897494 | ||
| The prognostic significance of sialyl-Tn antigen in women treated with breast carcinoma treated with adjuvant chemotherapy | Q73954438 | ||
| Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer | Q74430162 | ||
| Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model | Q39852463 | ||
| GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells | Q39866049 | ||
| Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc | Q40002603 | ||
| Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model. | Q40295896 | ||
| The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines. | Q40307071 | ||
| Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients | Q40343797 | ||
| ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. | Q40379188 | ||
| Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen | Q40423620 | ||
| Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration. | Q40446171 | ||
| Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids. | Q40468532 | ||
| Expression of sialyl-Tn epitopes on beta1 integrin alters epithelial cell phenotype, proliferation and haptotaxis. | Q40512613 | ||
| Overexpression of the alpha2,6-sialyltransferase, ST6Gal I, in a low metastatic variant of a murine lymphoblastoid cell line is associated with appearance of a unique ST6Gal I mRNA. | Q40920661 | ||
| The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen. | Q41358682 | ||
| Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy | Q41594089 | ||
| The c-Ha-ras oncogene induces increased expression of beta-galactoside alpha-2, 6-sialyltransferase in rat fibroblast (FR3T3) cells. | Q41641549 | ||
| Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer | Q41851439 | ||
| Lewis blood group antigens (a and b) in human breast tissues. Loss of Lewis-b in breast cancer cells and correlation with tumor grade | Q42041188 | ||
| Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. | Q42638803 | ||
| STn and prognosis in breast cancer. | Q43807787 | ||
| Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer | Q43984955 | ||
| Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer | Q44005423 | ||
| Sialyltransferase specificity in selectin ligand formation | Q44189769 | ||
| Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour | Q45270233 | ||
| A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression | Q46345968 | ||
| Elucidation of binding specificity of Jacalin toward O-glycosylated peptides: quantitative analysis by frontal affinity chromatography. | Q46715316 | ||
| Protein glycosylation: chaperone mutation in Tn syndrome | Q46776454 | ||
| Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients. | Q46977918 | ||
| Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model | Q47983745 | ||
| Acceptor specificity and tissue distribution of three human alpha-3-fucosyltransferases | Q48932467 | ||
| The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. | Q51801017 | ||
| Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. | Q52551217 | ||
| Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens | Q52828199 | ||
| The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). | Q52852287 | ||
| Study of the expression of Tn antigen in different types of human breast cancer cells using VVA-B4 lectin. | Q53350725 | ||
| Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. | Q53435760 | ||
| Inhibitors of carbohydrate processing: A new class of anticancer agents. | Q53461334 | ||
| Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis. | Q53468077 | ||
| Structures of neutral O-linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly-N-acetyllactosamine backbones with Gal beta(1-4)GlcNAc beta(1-6) repeating units. | Q54361734 | ||
| Absence of COSMC gene mutations in breast and colorectal carcinomas. | Q54543468 | ||
| Tumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic Cells | Q57195392 | ||
| The α(1,3)Fucosyltransferase Fuc-TVII Controls Leukocyte Trafficking through an Essential Role in L-, E-, and P-selectin Ligand Biosynthesis | Q60719538 | ||
| Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues | Q67721377 | ||
| Monoclonal Antibody B72.3 Reacts with a Core Region Structure of O-Linked Carbohydrates | Q68458808 | ||
| Proteinases and sialyltransferase in human breast tumors | Q70218697 | ||
| Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer | Q70708986 | ||
| T and Tn, general carcinoma autoantigens | Q71372455 | ||
| Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study | Q71698399 | ||
| Gangliosides expressed in human breast cancer | Q71767585 | ||
| Expression of sialyl-Tn in breast cancer. Correlation with prognostic parameters | Q73412818 | ||
| Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides | Q73429672 | ||
| Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma | Q73507939 | ||
| Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases | Q73583150 | ||
| Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients | Q73613891 | ||
| Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes | Q73701468 | ||
| P433 | issue | 3 | |
| P921 | main subject | breast cancer | Q128581 |
| breast neoplasm | Q23929670 | ||
| carbohydrate tumor-associated antigens | Q77299973 | ||
| P304 | page(s) | 204 | |
| P577 | publication date | 2010-06-08 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Tumour-associated carbohydrate antigens in breast cancer | |
| P478 | volume | 12 |
| Q55226110 | A One-Step Chemoenzymatic Labeling Strategy for Probing Sialylated Thomsen-Friedenreich Antigen. |
| Q64074407 | A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide |
| Q37290676 | Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes |
| Q52720447 | Activators and Effectors of the Small G Protein Arf1 in Regulation of Golgi Dynamics During the Cell Division Cycle. |
| Q34577155 | An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer |
| Q28278814 | Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements |
| Q34247281 | Antibody recognition of cancer-related gangliosides and their mimics investigated using in silico site mapping |
| Q89148025 | Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies |
| Q42321472 | Balancing life with glycoconjugates: monitoring unfolded protein response-mediated anti-angiogenic action of tunicamycin by Raman Spectroscopy |
| Q37625382 | Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers |
| Q37076109 | Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids |
| Q46388405 | Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy |
| Q35525289 | Cancer vaccines and carbohydrate epitopes |
| Q34478719 | Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines. |
| Q38016342 | Carbohydrate-based cancer vaccines: target cancer with sugar bullets |
| Q36501284 | Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies. |
| Q39231697 | Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation |
| Q90217150 | Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44 |
| Q47144276 | Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity |
| Q88598928 | Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer |
| Q36492855 | Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer |
| Q37624230 | Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis |
| Q50197234 | E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy |
| Q37711887 | Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma |
| Q46595783 | Enzymatic and Chemoenzymatic Syntheses of Disialyl Glycans and Their Necrotizing Enterocolitis Preventing Effects. |
| Q37372711 | Evaluation of glycophenotype in breast cancer by quantum dot-lectin histochemistry |
| Q36561625 | GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma |
| Q34058682 | Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients. |
| Q34988382 | Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing |
| Q50961166 | Glycoengineered cell models for the characterization of cancer O-glycoproteome: an innovative strategy for biomarker discovery. |
| Q37712277 | Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound |
| Q30382105 | Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors. |
| Q38757500 | Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability |
| Q35802482 | Glycosyltransferases as Markers for Early Tumorigenesis |
| Q35899406 | Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands |
| Q30843463 | HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma |
| Q39032812 | Harnessing benefit from targeting tumor associated carbohydrate antigens |
| Q39031683 | Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example |
| Q111347102 | Human alpha 1-acid glycoprotein as a model protein for glycoanalysis in baculovirus expression vector system |
| Q41478234 | Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis |
| Q33961477 | Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist |
| Q26740513 | Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines |
| Q39935587 | Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate |
| Q37679918 | Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance |
| Q39696121 | Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions. |
| Q35800918 | Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide |
| Q35705462 | Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines |
| Q64096546 | Liposomal Fc Domain Conjugated to a Cancer Vaccine Enhances Both Humoral and Cellular Immunity |
| Q40644424 | Liquid chromatography mass spectrometry-based O-glycomics to evaluate glycosylation alterations in gastric cancer |
| Q35953085 | Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice |
| Q35898801 | MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice. |
| Q36156434 | N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic |
| Q37137385 | Natural and Induced Humoral Responses to MUC1. |
| Q57169347 | Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids |
| Q57107715 | O-linked mucin-type glycosylation in breast cancer |
| Q38977538 | Osteopontin O-glycosylation contributes to its phosphorylation and cell-adhesion properties |
| Q47281580 | Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology? |
| Q39143578 | Over-sulfated glycosaminoglycans are alternative selectin ligands: insights into molecular interactions and possible role in breast cancer metastasis. |
| Q28536615 | Pinellia pedatisecta agglutinin targets drug resistant K562/ADR leukemia cells through binding with sarcolemmal membrane associated protein and enhancing macrophage phagocytosis |
| Q33838811 | Plant Lectins Targeting O-Glycans at the Cell Surface as Tools for Cancer Diagnosis, Prognosis and Therapy |
| Q34939938 | Pre- and post-translational regulation of osteopontin in cancer |
| Q52686871 | Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging. |
| Q34700620 | Primary breast cancer tumours contain high amounts of IgA1 immunoglobulin: an immunohistochemical analysis of a possible carrier of the tumour-associated Tn antigen. |
| Q37993590 | Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies |
| Q27027559 | Regulation of the metastatic cell phenotype by sialylated glycans |
| Q39453175 | Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. |
| Q38618833 | Sialic acids in biological and therapeutic processes: opportunities and challenges |
| Q58049239 | Sialyl Lewis x expression in cervical scrapes of premalignant lesions |
| Q33649572 | Sialyl-tn in cancer: (how) did we miss the target? |
| Q52344895 | Sialyltransferase-Based Chemoenzymatic Histology for the Detection of N- and O-Glycans. |
| Q36539502 | Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins |
| Q37661404 | Sticking to sugars at the metastatic site: sialyltransferase ST6GalNAc2 acts as a breast cancer metastasis suppressor |
| Q36297281 | Sulfonated Polyethylenimine for Photosensitizer Conjugation and Targeting |
| Q47141857 | Super-delta: a new differential gene expression analysis procedure with robust data normalization |
| Q34639786 | Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cells |
| Q98386361 | Synthetic MUC1 breast cancer vaccine containing a Toll-like receptor 7 agonist exerts antitumor effects |
| Q47819361 | Targeting cancer-specific glycans by cyclic peptide lectinomimics |
| Q47135344 | Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects. |
| Q35172546 | The emerging importance of α-L-fucose in human breast cancer: a review. |
| Q92648096 | Therapeutic anti-cancer activity of antibodies targeting sulfhydryl bond constrained epitopes on unglycosylated RON receptor tyrosine kinase |
| Q35904166 | Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides. |
| Q36186712 | Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens |
| Q34722755 | Total synthesis of trifluorobutyryl-modified, globally protected sialyl Lewis x by a convergent [2+2] approach |
| Q55167285 | Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau. |
| Q37512647 | Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches |
| Q35742481 | Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway |
| Q27684758 | α-L-fucosidase inhibition by pyrrolidine-ferrocene hybrids: rationalization of ligand-binding properties by structural studies |
Search more.